How to make the most out of the new Monocl

With the new release made today, you are able to search directly for publications, clinical trials and grant payments. This post covers some interesting new use cases that you likely will be interested in exploring.

Read more

How to make the most out of the new Monocl

With the new release made today, you are able to search directly for publications, clinical trials and grant payments. This post covers some interesting new use cases that you likely will be interested in exploring.

Read more

Win an annual subscription of Monocl! Register for Monocl’s Christmas Raffle

We are incredibly excited about what we have in store for you this week. We are now in the process of making the final touches on our greatest update since launch – a new version of Monocl. To celebrate, we are handing out two annual subscriptions of the new Monocl. Register for the Christmas Raffle to win a subscription!

Read more

Have you read the news? Introducing expert specific news feeds

Today, we are making millions of news articles, corporate press releases, blog posts, conferences, scientific forums and much more readily accessible on all the expert profiles in Monocl EGO.

Read more

Closing the innovation gap – Proper R&D externalization as a lever to pipeline growth

Externalization has been a frequently discussed topic and increasingly employed R&D strategy within Life Science for the last decade, but only 25% of companies have a clear strategy on how they will approach externalization. Here we try to shed light on the constituent parts that make up an external R&D strategy and the tools you should be using.

Read more

Aligning interests between CROs and Pharma – how to get more out of site feasibility and investigator selection

The early process of selecting sites and investigators for a clinical study is one of the most critical tasks in running trials, as it forms the foundation for successful recruitment rates. However, the process often lacks transparency and alignment of interests between the parties involved, creating a non-optimal outcome and by extension jeopardizes the success of the trial. We share our perspective on the issue…

Read more